MedPath

Investigating the effect of electrotherapy in improving uterine blood supply in women with a history of repeated IVF implantation failure

Not Applicable
Recruiting
Conditions
Infertility related to women with a history of at least two implantation failures (RIF)..
Female infertility
Registration Number
IRCT20230206057338N1
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
22
Inclusion Criteria

Female
Age between 20 and 40 years
History of at least two failed transfers
Embryo grade A or B

Exclusion Criteria

Having any of the cases of congenital anomaly of the uterus, fibroids or any intrauterine lesions, severe endometriosis, uterine myomas, uterine adenomyosis, ovarian cysts and antral follicles with sizes larger than 12 mm,
severe ovulation disorder including prolonged oligoamenorrhea, premature ovarian failure and hypothalamic amenorrhea,
suffering from any internal disease associated with blood flow disorders such as diabetes and dyslipidemia, smoking and alcohol consumption,
special diets such as vegetarianism,
autoimmune diseases,
hypertension and coagulation disorders,
intrauterine adhesions ( Asherman syndrome)and other organic injuries, uterine dysplasia,
mental illnesses, mental disorders,
contraindications for estrogen therapy,
anemia, hyperthyroidism, heart disease, liver disease, kidney disease, and other diseases that lead to a decrease in menstruation
People whose embryos are not grade A or B after resuscitation or the thickness of the endometrium is less than 6 mm on the day of endometrial conversion,

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcome: successful pregnancyoutcomes of the research. Timepoint: Before entering the study,12 weeks after implantation. Method of measurement: To check a successful pregnancy, the implantation rate, the number of gestational sacs and the growth of the fetus until the 12th week of pregnancy will be recorded and analyzed and compared.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath